SI-BONE Announces Launch of Public Offering of Common Stock
May 04, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE, Inc. Reports Financial Results for the First Quarter 2023 and Increases Annual Guidance
May 01, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., May 01, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
SI-BONE to Present at Bank of America Merrill Lynch 2023 Global Healthcare Conference
April 24, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE To Report First Quarter 2023 Financial Results on May 1, 2023
April 10, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., April 10, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE, Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Issues 2023 Guidance
February 27, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Feb. 27, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...
SI-BONE To Report Fourth Quarter 2022 Financial Results on February 27, 2023
February 06, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Feb. 06, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2022
January 09, 2023 09:00 ET
|
SI-BONE, Inc.
Fourth Quarter revenue of $31.7 - $31.9 million representing growth of approximately 26%Fiscal Year 2022 revenue of $106.1 - $106.3 million representing growth of approximately 18% SANTA CLARA,...
SI-BONE to Host a Virtual Fireside Chat at the 25th Annual Needham Growth Conference
January 03, 2023 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Jan. 03, 2023 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today...
SI-BONE, Inc. Announces FDA Clearance for Expanded Rod Compatibility with the iFuse Bedrock Granite® Implant System
December 27, 2022 08:30 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Dec. 27, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc., (Nasdaq: SIBN), a Silicon Valley-based medical device company dedicated to solving musculoskeletal disorders of the...
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2022 and Updates Guidance
November 07, 2022 16:09 ET
|
SI-BONE, Inc.
SANTA CLARA, Calif., Nov. 07, 2022 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq:SIBN), a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy, today reported...